1-3 of 3
Ravi Patel, MD
Close
Sort by
Journal Articles

Biological Effects of Abdominal Irradiation on Intestinal Barrier Breakdown Identified By Second-Generation Probiotic, LR-IL-22

Alexis Marie Espinal, Michael Epperly, PhD, Amitava Mukherjee, Donna Shields, Wen Hou, Renee Fisher, Jan-Peter van Pijkeren, Ravi Patel, MD, Naveed Islam, Joel S Greenberger, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139819
Published: 2020
Journal Articles

A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib and Dexamethasone (DVD) for Patients with Previously Untreated Multiple Myeloma (MM).

James R. Berenson, MD, Ori Yellin, MD, Ravi Patel, MD, Chien-Shing Chen, MD, Ralph Vincent Boccia, MD, Donald Colbourn, MD, Honghao (Hank) Yang, MD, PhD, Varun Gupta, MD, George F. Geils, Jr., MD, Youram Nassir, MD, Jacqueline Hilger, MS, Regina A. Swift
Journal: Blood
Blood (2009) 114 (22): 4936.
https://doi.org/10.1182/blood.V114.22.4936.4936
Published: 2009
Journal Articles

Bortezomib, Ascorbic Acid and Melphalan (BAM) Therapy for Patients (pts) with Newly Diagnosed Multiple Myeloma (MM): An Effective and Well-Tolerated Frontline Regimen.

James R. Berenson, MD, Ori Yellin, MD, Donald Woytowitz, MD, Marshall S. Flam, MD, Alan Cartmell, MD, Ravi Patel, MD, Herb Duvivier, MD, Youram Nassir, MD, Regina A. Swift, RN
Journal: Blood
Blood (2007) 110 (11): 3602.
https://doi.org/10.1182/blood.V110.11.3602.3602
Published: 2007